FIGURE
Fig. 5
- ID
- ZDB-FIG-250106-13
- Publication
- Dernov?ek et al., 2024 - First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 5
Structure-activity relationship summary for on-target activity and antiproliferative activity in cancer cells. 3,4-Dichloro-5-methylpyrrolamide (in blue) moiety is critical for dual-target inhibition, while its replacement with the 3,4-dichlorobenzamide (in blue) moiety results in selective Hsp90 CTD inhibition. Introduction of the methoxy group on the adjacent phenyl ring (in yellow) results in equipotent activity, while modification of the nitrogen-based heterocycle (in magenta) results in the most pronounced effects on target inhibition and antiproliferative activity. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Bioorg. Chem.